Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section text now states that publications are automatically populated from PubMed and may not pertain to the study. A Revision: v3.3.2 tag was added, replacing the previous v3.2.0.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding lapse notice about data currency and site operations has been removed, and the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedThe update appears to be formatting/layout adjustments on the Study Details page without modifying core content (e.g., eligibility criteria, outcome measures, or study status). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedCore content updated with a government funding notice and the NIH Clinical Center operating status, plus a version bump to v3.2.0.SummaryDifference3%

- Check70 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion bump: v3.0.1 -> v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or stock.SummaryDifference0.2%

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.